Omicron is a variant of SARS-CoV-2 that has caused a series of cases in South Africa and is currently spreading around the world. Similar to previous variants that have attracted attention, thisRead More…
08Dec/21
08Dec/20
Understanding the Cytokine Storm of COVID-19
Background Recent reports that elevated serum cytokine levels are associated with the 2019 coronavirus (COVID-19) have raised questions about the relationship between cytokine storm and severe complications of this infection. The purposeRead More…
08Dec/20
The Impact of COVID-19 on Biopharmaceutical R&D —Business Significance
Global Economic Outlook COVID-19 is tipping the global economy into a tailspin, wiping out years of market gains. The recession in 2020 is expected to be greater than the 2007-08 crisis: GlobalRead More…
08Nov/20
The Impact of COVID-19 on Biopharmaceutical R&D—Turn Crisis into Opportunity
COVID-19 Drug Development Status Pharma Intelligence Latest daily statics 456 R&D pipeline drugs 2451 clinical trials The gap between experimentation and industry progress These trials are largely sponsored by academia and government,Read More…
08Oct/20
SARS-CoV-2 New Review
At the end of 2019, an infectious pneumonia (COVID-19) caused by the novel coronavirus (SARS-CoV-2) began to spread around the world. Regardless of the number of infected people or the spatial extentRead More…